selected publications
-
article
- Cytidine deaminase deficiency in tumor cells is associated with sensitivity to a naphthol derivative and a decrease in oncometabolite levels. Cellular and Molecular Life Sciences. 2022
- A decrease in NAMPT activity impairs basal PARP-1 activity in cytidine deaminase deficient-cells, independently of NAD+. Scientific Reports. 2020
- Cytidine Deaminase Deficiency Reveals New Therapeutic Opportunities against Cancer. Clinical Cancer Research. 2017
-
document